Stay updated on Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.

Latest updates to the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision metadata updated from v3.2.0 to v3.3.2; no user-facing content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedBranding and navigation updates add references to the Moffitt Cancer Center Clinical Trials website and related entities, along with helpful links; a government funding operating-status notice was removed.SummaryDifference0.6%

- Check42 days agoChange DetectedUpdated study record dates: Enrollment (Actual) 13 and Study Completion (Actual) 2025-08-21, plus Last Update Posted 2025-10-01. The rest of the study details appear unchanged.SummaryDifference0.3%

- Check71 days agoChange DetectedCore content and status/version information updated: old recruitment/status indicators removed; newer operating status notice and updated dates/revision added.SummaryDifference4%

- Check78 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated to v3.0.2, indicating a minor content update. The older v3.0.1 tag was removed, and the 'Back to Top' element was deleted.SummaryDifference0.2%

Stay in the know with updates to Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.